ReP USP - Resultado da busca

Artigo de periodico
Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction (2022)
Docherty, Kieran F; Ogunniyi, Modele O; Anand, Inder S; Desai, Akshay S; Diez, Mirta; Howlett, Jonathan G; Nicolau, Jose Carlos ; O'meara, Eileen; Verma, Subodh; Inzucchi, Silvio E
Source: Jacc-heart failure. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, FÁRMACOS SINTÉTICOS, MORTALIDADE HOSPITALAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOCHERTY, Kieran F et al. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, v. 10, n. 1, p. 52-64, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jchf.2021.08.006. Acesso em: 06 nov. 2024.
APA
Docherty, K. F., Ogunniyi, M. O., Anand, I. S., Desai, A. S., Diez, M., Howlett, J. G., et al. (2022). Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, 10( 1), 52-64. doi:10.1016/j.jchf.2021.08.006
NLM
Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006
Vancouver
Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006
Artigo de periodico
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022)
Butler, Javed ; Anker, Stefan D ; Lund, Lars H. ; Coats, Andrew J. S.; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; FRIEDE, Tim ; Fabien, Vincent ; Kosiborod, Mikhail; Metra, Marco
Source: European heart journal. Unidade: FM
Subjects: PLACEBOS, POTÁSSIO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTLER, Javed et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, v. 43, n. 41, p. 4362-4373, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50465. Acesso em: 06 nov. 2024.
APA
Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G., Siddiqi, T. J., et al. (2022). Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, 43( 41), 4362-4373. doi:10.1093/eurheartj/ehac401
NLM
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
Vancouver
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
Artigo de periodico
The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2021)
Jankowska, Ewa A; Kirwan, Bridget-Anne; Kosiborod, Mikhail; Butler, Javed; Anker, Stefan D; Mcdonagh, Theresa; Dorobantu, Maria; Drozdz, Jaroslaw; Filippatos, Gerasimos; Nicolau, Jose Carlos
Source: European heart journal. Unidade: FM
Subjects: FERRO, INSUFICIÊNCIA CARDÍACA, FERRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANKOWSKA, Ewa A et al. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, v. 42, n. 31, p. 3011-+, 2021Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab234. Acesso em: 06 nov. 2024.
APA
Jankowska, E. A., Kirwan, B. -A., Kosiborod, M., Butler, J., Anker, S. D., Mcdonagh, T., et al. (2021). The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, 42( 31), 3011-+. doi:10.1093/eurheartj/ehab234
NLM
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehab234
Vancouver
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehab234

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration